1. Pepstatinyl-cystamine was synthesized. The disulphide bond was cleaved and the pepstatin-bound thiol group was made to react with monobromobimane. The fluorescent N-pepstatinyl-S-bimanyl-2-aminoethanethiol was purified. 2. Human cathepsin D showed tight binding of the bimane-labelled pepstatin at pH 3.5. The titration curves were used to determine the apparent dissociation constant, KD; values of approx. 1 x 10-1'M were obtained. 3. Gel-chromatographic experiments showed that, like that of pepstatin, the binding of N-pepstatinyl-S-bimanyl-2-aminoethanethiol to cathepsin D was strongly pH-dependent. Binding was seen at pH 5.0, but could not be demonstrated at pH 7.4. 4. Cultured human synovial cells were fixed and incubated with the fluorescent inhibitor at pH 5.0 or pH 7.4. When examined by fluorescence microscopy the cells stained at pH 5.0 showed a punctate perinuclear distribution of bimane fluorescence. By contrast, the cells stained at pH 7.4 showed no fluorescence. 5. The distribution of cathepsin D, determined by indirect immunofluorescence at pH 7.4, closely resembled that of the fluorescent inhibitor seen at pH 5.0. 6. We conclude that N-pepstatinyl-S-bimanyl-2-aminoethanethiol active conformation of cathepsin D.
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We have proposed (Knight et al., 1980) a new method for the subcellular location of proteinases that may be active under the conditions existing in living tissues. Briefly, the method employs the enzyme-antibody capture technique developed by Poole et al. (1973 Poole et al. ( , 1974 to immobilize and accumulate the proteinase as insoluble immune complexes at the sites of release in the living tissue. These complexes are then treated in situ with a tight-binding, or irreversible, active-site-directed inhibitor carrying a 'reporter' group. Since such inhibitors require the native active enzyme structure for efficient interaction (Knight, 1977) , the binding of the inhibitor, assuming no non-specific interactions, demonstrates the presence of active enzyme in the immune complex.
In our initial studies (Knight et al., 1980) we analysed the interaction between cathepsin D (EC Abbreviations used: bimanyl, 3, 6, 
amino-3-hydroxy-6-methylheptanoic acid]. The bifunctional N-pepstatinyl-N'-Dnp-1,6-diaminohexane was able to bind cathepsin D and fluoresceinlabelled antibody to Dnp simultaneously. Because the cathepsin D-pepstatin interaction is stoicheiometric (Knight & Barrett, 1976) , it is probable that subcellular location of enzyme via the binding of fluorescent anti-Dnp antibody will be a more sensitive method than the direct localization of a fluorescent inhibitor, especially since the commonly employed fluorophores are readily photobleached (Nairn, 1969) . This quenching phenomenon can only be overcome by employing multiply-labelled antibodies.
However, Kosower et al. (1978) have developed a new class of fluorescent labelling agents, the bromobimanes (Kosower & Pazhenchevsky, 1980) . These reagents react with thiol groups to give highly fluorescent products, which are resistant to fading under conditions of continuous irradiation (Kosower et al., 1979 , such as those employed in fluorescence microscopy (Gainer & Kosower, I . T. W. Matthews, R. S. Decker and C. G. Knight 1980) . We report below the synthesis and inhibitory properties of a bimane-labelled pepstatin and describe its application to the subcellular location of lysosomal cathepsin D in cultured human synovial cells.
Materials and methods

Biochemical reagents
Pepstatin was from Protein Research Foundation, Osaka, Japan. Benzotriazol-l-yloxytris(dimethylamino)phosphonium hexafluorophosphate (BOP) (Castro et al., 1976) (64,u1, 460,umol) and BOP (13 mg, 29,pmol) were added. After the mixture had been stirred at 210 C for 24 h, the solvent was evaporated at 400C in vacuo. The residue was dissolved in ethanol (1 ml), and applied to a column (1cm x 60 cm) of Sephadex LH-20 and eluted with ethanol (12 ml/h). Fractions (1 ml) representing the first ninhydrin-positive peak eluted from the column were combined and evaporated to dryness (9.5 mg), the residue was redissolved in aq. 50% (v/v) methanol (1.5 ml) and the solution was applied to a column (1cm x 10cm) of AG-50W-X2 (triethylammonium form). The column was washed with aq. 50% (v/v) methanol (65 ml), and N-pepstatinylcystamine was eluted with methanol/water/triethylamine (9:9:2, by vol.). The ninhydrin-positive fractions were evaporated to dryness at 40°C in vacuo to give a colourless solid. N-Pepstatinylcystamine (yield: 6mg, 50%) was homogeneous by t.l.c. on silica gel (RF 0.6; methanol) and was used without further purification.
Synthesis of N-pepstatinyl-S-bimanyl-2-aminoethanethiol N-Pepstatinyl-cystamine (3mg, 3.7,umol) in methanol (0.5 ml) was added to dithiothreitol (0.56mg, 3.7,umol) in 20mM-sodium borate buffer, pH8.0 (0.5ml). The mixture was stirred for 30min at 21 OC, and monobromobimane (5 mg, 18,umol) in acetonitrile (0.2 ml) was added. After the mixture had been left in darkness at 210C for 48h, the solvent was evaporated at 400C in vacuo. The residue was dissolved in ethanol (1 ml), and was applied to a column (lcm x 60cm) of Sephadex LH-20 and eluted with ethanol (12 ml/h). A portion (1,ul) of each fraction (1 ml) was taken for the assay of cathepsin D inhibition (Knight & Barrett, 1976) . Inhibitory fractions that fluoresced under u.v. light (365 nm) were combined and evaporated to yield a yellow solid (1.5mg). This material was dissolved in methanol (0.2 ml) and applied to a silica-gel preparative layer chromatography plate, which was developed in methanol. The major yellow and u.v.-fluorescent band was scraped off and eluted with ethyl acetate/ethanol (2:1, v/v; 2 ml). The solvents were removed at 400C in vacuo to leave N-pepstatinyl-S-bimanyl-2-aminoethanethiol (0.65 mg, 19%). This material was ninhydrinnegative and homogeneous by t.l.c. (RF 0.80, methanol; RF 0.20, . It was used without further purification. Fluorescence excitation and emission spectra were recorded with a Farrand mark 1 spectrofluorimeter.
Inhibitor titrations with cathepsin D Cathepsin D activity was measured under the standard assay conditions as described by Barrett (1970) , with approx. 1 unit of activity and a 20min incubation time. One unit of activity is defined as that producing an increase in absorbance (AA 280) of 1.0 in the assay during 60min under the specific conditions, a linear response being assumed. Inhibitor titrations were made as described previously (Knight & Barrett, 1976; Knight et al., 1980) .
Gel-filtration experiments were made at pH 5.0 and pH 7.4 with a column (1.5 cm x 26 cm, 46 ml) of Sephadex G-100 eluted with the appropriate buffer at 40 C. The buffering components were 50 mMsodium acetate/acetic acid at pH 5.0 and 50mM-NaH2PO4/NaOH at pH7.4. Both buffers contained 0.IM-NaCl and 0.1% Brij 35. Cathepsin D (50 units, 1.37 nmol) and N-pepstatinyl-S-bimanyl-2-aminoethanethiol (0.322pg, 0.34 nmol) were mixed in elution buffer (1ml) and left at 21°C for 10min before being applied to the column. The flow rate was 15ml/h and 0.8ml fractions were collected. A portion (0.1 ml) of each fraction was taken for assay of cathepsin D activity. A further portion (0.7 ml) was taken for the measurement of bimane fluorescence. The elution characteristics of the column were determined with standards of known molecular weight as described by Knight et al. (1980) Vol. 199 After rinsing the coverslips were immersed in N-pepstatinyl-S-bimanyl-2-aminoethanethiol (1lUM) at either pH 5.0 or 7.4 and incubated in a moist atmosphere for 30min at 21 IC. The cells were then briefly rinsed in the corresponding buffer and mounted in glycerol.
Fluorescence microscopy
The cells were examined in a Leitz Ortholux fluorescence microscope equipped with a 200W mercury vapour lamp. Bimane fluorescence was excited between 360 and 400nm by using a Leitz BG12 and a Balzers KI filter combination. Optimal bimane fluorescence was observed with the use of a Leitz Ploem 2 emission filter complex with a 460nm bandpass filter. All observations were recorded on Kodak Tri-X, or on Ektachrome 400 film that was uprated to ASA 1600.
Immunohistochemical subcellular location
Human synovial cells were fixed with paraformaldehyde at pH 7.4 in the phosphate-buffered saline as described above. 
Results
Synthesis of N-pepstatinyl-S-bimanyl-2-aminoethanethiol
Monobromobimane is a non-fluorescent compound that forms highly fluorescent products when the bromine atom is displaced by a suitable nucleophile, such as a thiol group (Kosower et al., 1979) . In order to label pepstatin with the bimane fluorophore it was necessary to synthesize a derivative carrying a free thiol group. We therefore coupled the disulphide cystamine to the free carboxy group of pepstatin, cleaved the disulphide bond with 1 mol.-equiv. of dithiothreitol (Cleland, 1964) and made the liberated thiol group react with mono-bromobimane. N-Pepstatinyl-S-bimanyl-2-aminoethanethiol ( Fig. 1) in aqueous solution had a fluorescence excitation maximum at 380nm, with an emission maximum at 460nm.
Inhibition of cathepsin D by N-pepstatinyl-Sbimanyl-2-aminoethanethiol
N-Pepstatinyl-S-bimanyl-2-aminoethanethiol behaved like pepstatin and bound tightly and stoicheiometrically to human cathepsin D at pH3.5. The shape of the titration curve (Fig. 2) enabled the calculation of an apparent dissociation constant, KD' from the deviation from stoicheiometric inhibition in the region of the equivalence point (Green & Work, 1953; Knight & Barrett, 1976) . Two independent experiments gave KD values of 1.4 x 10-1'M and 0.9 x 10-10M. Since the precise concentration of the inhibitor was not known, the cathepsin D concentration used in the assays was defined by titration with pepstatin (Knight & Barrett, 1976) Pepstatin-CO-NH-CH2-CH2-S-CH2 CH3 Fig. 1 . Structure of N-pepstatinyl-S-bimanyl-2-aminoethanethiol ethanethiol determined from the equivalence points was equal to the apparent weight concentration, indicating the absence of non-inhibitory impurities.
Effect ofpH on the stability ofthe enzyme-inhibitor complex We have shown previously (Knight & Barrett, 1976; Knight et al., 1980) that radiochemically labelled derivatives of pepstatin remained bound to cathepsin D during gel-permeation chromatography on Sephadex G-100 at pH5.0 N-Pepstatinyl-Sbimanyl-2-aminoethanethiol behaved similarly, and all the detectable fluorescence eluted from the column was found in fractions that also contained enzyme (Fig. 3a) . However, at pH7.4 the fractions containing cathepsin D were not fluorescent (Fig.  3b) . These results were very similar to those obtained with pepstatin and pepstatinyl-[ 3Hlglycine (Knight & Barrett, 1976 (Barrett, 1977) . We have used this phenomenon to distinguish between active-site-directed and nonspecific binding of the fluorescent inhibitor. lInhibitorl (nM) Fig. 2 . Inhibition of cathepsin D by N-pepstatinvl-S-bimanyl-2-aminoethanethiol Standard assay conditions were used as described by Barrett (1970) . The assays were started by the addition of buffered haemoglobin to the mixture of cathepsin D and inhibitor at 450 C. After 20min the trichloroacetic acid-soluble products of digestion of haemoglobin were measured by their A 280. Vol. 199
We concluded from these results that at pH 5.0 N-pepstatinyl-S-bimanyl-2-aminoethanethiol was a selective fluorescent probe for the active conformation of the lysosomal cathepsin D.
Discussion
Fluorescent substrates and inhibitors of proteinases have been used primarily in studies of active-site specificity and polarity (Fruton, 1980) . inhibitor specific for cathepsin D in the active conformation and it contains the photostable bimane fluorophore. The binding characteristics were very similar to those of other pepstatin derivatives (Knight & Barrett, 1976; Knight et al., 1980) , although somewhat lower values of the apparent dissociation constant, KD, at pH3.5 were obtained. At pH 7.4 binding of the inhibitor to the free enzyme or to the enzyme in lysosomes could not be demonstrated.
Monobromobimane was chosen as the labelling reagent because reaction with thiols gives highly fluorescent products that resist photobleaching (Kosower et al., 1979; Gainer & Kosower, 1980) . In preliminary experiments (I. T. W. Matthews, W. Hornebeck & C. G. Knight, unpublished work) we had prepared fluorescent inhibitors by reaction of N-pepstatinyl-1,2-diaminoethane with dansyl (5-dimethylaminonaphthalene-1-sulphonyl) chloride or Lissamine Rhodamine B sulphonyl chloride. The fluorescence of the dansyl derivative was lost during the purification in daylight, and the Rhodamine derivative faded rapidly in the fluorescence microscope. By contrast, the bimane-labelled pepstatin could be isolated readily without decomposition, and cells stained with this reagent at pH 5.0 could be examined in the microscope without an appreciable decrease in fluorescence intensity.
A notable feature of the location studies was the absence of non-specific staining. This was particularly apparent in the cells treated with Npepstatinyl-S-bimanyl-2-aminoethanethiol at pH 7.4 (Plate lb), but even at pH 5.0 the distribution of bimane fluorescence among the cells was uneven (Plate la), closely resembling in this respect the cells stained by the indirect immunofluorescent method (Plate 1 c). Nor was the extent and pattern of staining changed when the pepstatinyl-bimane concentration was increased to 100pM. It appears, therefore, that the only factor controlling the extent of fluorescent inhibitor binding at pH 5.0 is the intracellular content of cathepsin D.
The subcellular distribution of cathepsin D revealed by N-pepstatinyl-S-bimanyl-2-aminoethanethiol (Plate 1 a) was very similar to that seen by the immunohistochemical method (Plate 1 c). Both techniques showed that in human synovial cells cathepsin D resides primarily within a perinuclear array of granules, although a pattern of somewhat more diffusely stained material was often seen in the cytoplasm (Plate 1 a) . Clearly, most of the enzyme is in secondary lysosomes (Poole et al., 1972; Decker & Wildenthal, 1980) , but our observations imply that cathepsin D can also be found elsewhere in the cell. This apparent dual subcellular location of the enzyme may be explained by the studies conducted by Erickson & Blobel (1979) . They demonstrated that cathepsin D was synthesized and glycosylated within the rough endoplasmic reticulum, and it seems possible that our diffuse fluorescence may represent newly synthesized enzyme en route to the lysosomal vacuolar apparatus.
Our present observations demonstrate a great potential for developing labelled active-site-directed inhibitors for the location of specific enzymes within the cell. Unlike the immunohistochemical approach, which requires extensive enzyme purification and antibody production before location studies can begin, the pepstatin probes are specific for the aspartate proteinases regardless of species (Barrett, 1977) . An additional advantage of such reagents is that they allow the distribution of potential enzyme activity to be assessed. With the current development of techniques for the introduction of lowmolecular-weight probes into living cells (cf. Barack et al., 1980) it may be possible to use specific probes to reveal where a particular enzyme is physiologically functional within the cell. I. T. W. M. thanks the Nuffield Foundation for financial support. R. S. D. is an Established Investigator of the American Heart Association.
